Beta Bionics, Inc. BBNX
We take great care to ensure that the data presented and summarized in this overview for Beta Bionics, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in BBNX
Top Purchases
Top Sells
About BBNX
Insider Transactions at BBNX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 31
2025
|
Mike Mensinger Chief Product Officer |
BUY
Open market or private purchase
|
Direct |
33,350
+36.11%
|
$566,950
$17.0 P/Share
|
|
Jan 31
2025
|
Mike Mensinger Chief Product Officer |
SELL
Open market or private sale
|
Direct |
13
-0.05%
|
$221
$17.0 P/Share
|
|
Jan 31
2025
|
Mike Mensinger Chief Product Officer |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
10,575
+29.17%
|
$0
$0.02 P/Share
|
|
Jan 31
2025
|
Mike Mensinger Chief Product Officer |
BUY
Conversion of derivative security
|
Direct |
15,107
+50.0%
|
-
|
|
Jan 31
2025
|
Wellington Hadley Harbor Aggregator Iv, L.P. |
BUY
Open market or private purchase
|
Direct |
1,000,000
+20.4%
|
$17,000,000
$17.0 P/Share
|
|
Jan 31
2025
|
Wellington Hadley Harbor Aggregator Iv, L.P. |
BUY
Conversion of derivative security
|
Direct |
2,901,599
+50.0%
|
-
|
Last 12 Months Summary
Buy / Acquisition
3.96M
Shares
From
5
Insiders
| Conversion of derivative security | 2.92M shares |
|---|---|
| Open market or private purchase | 1.03M shares |
| Exercise of in-the-money or at-the-money derivatives securities | 10.6K shares |
Sell / Disposition
13
Shares
From
1
Insiders
| Open market or private sale | 13 shares |
|---|